Forte Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.50
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.15
|
-0.18
|
-0.03
|
-20.00%
|
|
2022-06-30
|
-0.32
|
-0.21
|
0.11
|
34.38%
|
|
2022-03-31
|
-0.17
|
-0.17
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.32
|
-0.21
|
0.11
|
34.38%
|
|
2021-09-30
|
-0.36
|
-0.54
|
-0.18
|
-50.00%
|
|
2021-06-30
|
-0.43
|
-0.43
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.52
|
-0.36
|
0.16
|
30.77%
|
|
2020-12-31
|
-0.57
|
-0.37
|
0.20
|
35.09%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.56
|
|
2021-12-31
|
-1.54
|
|
2020-12-31
|
-16.79
|
|
2019-12-31
|
-41.10
|
|
2018-12-31
|
-36.60
|
|
2017-12-31
|
-5.72
|